Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
8 hedge funds and large institutions have $67.8K invested in Vaxxinity, Inc. Class A Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 50 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
86% less funds holding
Funds holding: 58 → 8 (-50)
99% less capital invested
Capital invested by funds: $8.73M → $67.8K (-$8.66M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 50
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$56.8K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.15M |
| 2 |
BlackRock
New York
|
-$1.88M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.73M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$630K |
| 5 |
State Street
Boston,
Massachusetts
|
-$573K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| – | -$3.47K | -4,840 | Closed |
|
|
AIP
52
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$2.52K | -3,519 | Closed |
|
|
AWM
53
Avior Wealth Management
Omaha,
Nebraska
| – | -$1.48K | -2,056 | Closed |
|
|
AB
54
Amalgamated Bank
New York
| – | -$1K | -1,437 | Closed |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -974 | Closed |
|
|
EBA
56
Eagle Bay Advisors
New York
| – | -$508 | -708 | Closed |
|
|
SSB
57
Sandy Spring Bank
Olney,
Maryland
| – | -$72 | -100 | Closed |
|
VAXX Hedge Fund Activity: Q2 2024 in Review
8 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q2 2024, worth a combined $67.8K — down 99% from $8.73M a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of VAXX and 0 opened new positions — a net loss of 50 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Spire Wealth Management, adding an estimated $56.8K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $2.15M sold.
- 8 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q2 2024, down from 58 in Q1 2024.
- Funds reported $67.8K of Vaxxinity, Inc. Class A Common Stock stock for Q2 2024, down 99% quarter-over-quarter.
- 0 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q2 2024 and 50 closed out, a net change of -50 holders.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q2 2024 was Spire Wealth Management, an estimated $56.8K added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q2 2024 was Adage Capital Partners, an estimated $2.15M sold.
Based on aggregated 13F filings for Q2 2024.